Cardiff Lexington Corporation (CDIX)
OTCMKTS · Delayed Price · Currency is USD
1.710
+0.010 (0.59%)
At close: Dec 15, 2025
Cardiff Lexington Market Cap
Cardiff Lexington has a market cap or net worth of $34.12 million as of December 16, 2025. Its market cap has increased by 29,249.45% in one year.
Market Cap
34.12M
Enterprise Value
100.44M
Revenue
11.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.71
Market Cap Chart
Since July 19, 2004, Cardiff Lexington's market cap has increased from 3.75M to 34.12M, an increase of 811.07%. That is a compound annual growth rate of 10.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 34.12M | 9,352.83% |
| Dec 29, 2023 | 360.98K | 40.97% |
| Dec 29, 2022 | 256.06K | 10.12% |
| Dec 31, 2021 | 232.53K | 142.94% |
| Dec 31, 2020 | 95.71K | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |